Related Experiment Video
Updated: May 30, 2026

08:08
qPCR Is a Sensitive and Rapid Method for Detection of Cytomegaloviral DNA in Formalin-fixed, Paraffin-embedded Biopsy Tissue
Published on: July 9, 2014
Screening for cytomegalovirus during pregnancy
1Medical College of Virginia Campus, Virginia Commonwealth University, P.O. Box 980163, Richmond, VA 23298-0163, USA. Sadler@vcu.edu
Infectious Diseases in Obstetrics and Gynecology
|August 13, 2011
Summary
Cytomegalovirus (CMV) screening in pregnancy is becoming more feasible due to advances in understanding pathogenesis, identifying high-risk individuals, and improved diagnostic methods for both mothers and newborns.
Area of Science:
- Obstetrics and Gynecology
- Infectious Diseases
- Perinatal Medicine
Background:
- Cytomegalovirus (CMV) infections in pregnant women are a significant concern.
- Decades of research have focused on CMV epidemiology and pathogenesis.
Purpose of the Study:
- To highlight recent advancements making CMV serologic screening during pregnancy more attractive.
- To review developments in understanding CMV pathogenesis and diagnosis.
Main Methods:
- Review of recent developments in CMV research.
- Analysis of diagnostic methods for maternal and fetal CMV infection.
- Evaluation of indicators for neonatal outcomes.
Main Results:
- Understanding of CMV pathogenesis has advanced.
- Accurate serologic diagnostic methods for primary CMV infection are available.
- Methods for diagnosing fetal infection and predicting neonatal outcomes have improved.
- Potentially effective interventions are emerging.
Conclusions:
- Recent developments support the potential attractiveness of universal or limited serologic screening for CMV in pregnant women.
- Improved diagnostics and understanding of pathogenesis facilitate better management and outcomes.
More Related Videos
Related Concept Videos
Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...

